Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by CCAbbott888on May 01, 2019 10:22am
170 Views
Post# 29694469

RE:RE:RE:RE:RE:RE:RE:RE:be careful what u wish for

RE:RE:RE:RE:RE:RE:RE:RE:be careful what u wish for
Francois33 wrote: Everyone wants to lower their cost average without new money, this is not the point.
Are you ready (in the actual context) to put 5 000$, 10 000$, 15 000$, 20 000$  of what's left in your account with PLI.

Lost enought already, context has to change. This will be a very miticulous decision, on my side.

Francois33

Francois33  I don't disagree with your principle.  However, I think that this is a question for each investor to answer for themselves (e.g. whether or not they want to continue to invest in this company under the new equity structure, given the recent events).  However, different people do have different criteria and time frame in which they make their investment decisions.

My thoughts is that while each take time to decide, it's important to stay focused on the more pressing issue, which is the decision to buy the rights offer or not and if yes, what is the necessary (or the best) plan that will work for each person's situation.

In my opinion, even if one is to decide to move on completely in the near term, it still makes sense to try to reduce the loss as much as possible by participating in the rights offer, as presented in April 15 PR. 

Realistically, I see very little possibility of the refinancing (closed on April 23) being un-done, or reversed, after TMX granted their approval and AMF's uneffective cc yesterday.  For the retailers, their options are thus very limited. GL!
Bullboard Posts